The Effects of Whey Protein Supplements on Markers of Exercise-induced Muscle Damage in Resistance-trained Individuals
Launched by INDIANA UNIVERSITY · Oct 19, 2021
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Eccentric exercise can result in exercise induced muscle damage (EIMD), which can cause an abundance of ultrastructural muscular disruption and pro-inflammatory and pro-oxidant activity in the body, leading to an impairment of muscular force production and range of motion, along with elevated pain sensitivity, increased swelling, and arterial stiffness. Pasture-raised dairy products, obtained from strictly grass-fed cows, have been shown to possess more anti-inflammatory-, antioxidant-, and antihypertensive-like biochemicals compared with conventional products (i.e., with a different nutrie...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women 18-40 years old
- • ≥3 months uninterrupted training of ≥3 days/week of resistance training
- • Self-reported to be healthy
- Exclusion Criteria:
- • Not within defined age range
- • History of allergy to dairy products
- • History of experiencing pain while exercising in the lower extremities (i.e., hips/knees)
- • Current use of anti-inflammatory/anti-pain medication (i.e., nonsteroidal anti-inflammatory drugs (NSAIDs) such as Tylenol, Advil, or Aleve
- • Are pregnant or could possibly be pregnant by self-report
- • People who answer 'yes' to any of the pre-participation screening questions on the PAR-Q questionnaire.
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bloomington, Indiana, United States
Patients applied
Trial Officials
Timothy D Mickleborough, Ph.D.
Principal Investigator
Indiana University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials